Contact
Please use this form to send email to PR contact of this press release:
Histogenics Corporation Announces Amendment to NeoCart® Phase 3 Clinical Trial Enrollment Criteria
TO:
Please use this form to send email to PR contact of this press release:
Histogenics Corporation Announces Amendment to NeoCart® Phase 3 Clinical Trial Enrollment Criteria
TO: